You searched for "presentation"
Conference Report: Uveitis-North West: Weaving a vision at the Whitworth Art Gallery
“It is necessary to mark the greater from the lesser truth: namely the larger and more liberal idea of nature from the comparatively narrow and confined; namely that which addresses itself to the imagination from that which is solely addressed...
Atlas Optical Coherence Tomography of Macular Diseases and Glaucoma
The book is divided into three sections: an introduction to optical coherence tomography (OCT), the OCT in macular diseases, and glaucoma. The first section lists the currently commercially available OCT machines, then describes the techniques for acquiring OCT images using...
Ocular manifestations of Whipple’s disease
In this retrospective review of 217 patients with Whipple’s disease (WD), the authors reviewed the presentations of those with ocular manifestations. Ocular signs of WD are under recognised, frequently resulting in misdiagnosis and mismanagement. Mayo Data Explorer, a Mayo Clinic...New study maps priorities for UK eyecare research
Glaucoma, age-related macular degeneration, childhood vision loss, and short-sightedness are highlighted as target study areas.Strengthening diabetic retinopathy services in Nigeria through DR-NET – from grass roots to national policy development
This is the third article in a series (see Part 1 and Part 2) reflecting on how shared learning via networks of UK and international eye health professionals is contributing to reducing unnecessary blindness in Nigeria. Earlier articles focused on...
How to achieve 1% solution of Lissamine green
Lissamine green (LG) concentration of 1% is clinically effective in the diagnosis of ocular surface disease. LG is now commercially available only in a form of dye-impregnated strips, whose concentration is insufficient. This study examined how to achieve 1% concentration...Practice Plus Group: Mastering vitreoretinal pathology assessment in community optometry
Practice Plus Group Ophthalmology are delighted to offer a virtual accredited event for local referrers: ‘Mastering vitreoretinal pathology assessment in community optometry’In this course, optometrists will master the art of assessing and distinguishing between common vitreoretinal pathologies right from their...BOAS 2025 Annual Scientific Meeting
We are excited to announce the upcoming 23rd BOAS Annual Scientific Meeting, which will be held at the prestigious Royal Society of Medicine in London on Thursday 4th and Friday 5th September 2025. This event offers an exceptional opportunity for...SPROGS 2026
Scottish Paediatric Regional Ophthalmologists’ Group 2026 MeetingNon-organic visual loss
Patients can present to eye departments with various signs and symptoms (mostly symptoms) with no obvious organic cause. These patients can be labelled with any of a wide range of diagnoses such as functional visual loss, functional overlay, psychosomatic reaction...
Efficacy and safety of novel PF brimonidine / timolol fixed-combination ophthalmic solution for OAG
This study is a multicentre, randomised, open-label, parallel-group clinical trial to evaluate the efficacy and safety of a newly developed preservative-free (PF) brimonidine / timolol fixed-combination (BTFC) ophthalmic solutions as compared with preservative-containing (PC) BTFC ophthalmic solution in adult patients...
